Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction

OBJECTIVES: To explore that if mid-regional sequence of pro-A-type natriuretic peptide (MR-proANP) may have a good value of diagnosis in heart failure with preserved ejection fraction (HFpEF) compared with N-terminal pro-B-type natriuretic peptide (NT-proBNP). METHODS: Participants with cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Kun, Huang, Wei, Fan, Jinqi, Lei, Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133645/
https://www.ncbi.nlm.nih.gov/pubmed/30200170
http://dx.doi.org/10.1097/MD.0000000000012277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133645/
https://www.ncbi.nlm.nih.gov/pubmed/30200170
http://dx.doi.org/10.1097/MD.0000000000012277

Ejemplares similares